IL33 and systemic sclerosis: IL-1α, IL-1β, and IL-18 were significantly upregulated in skin lesions of patients with SSc, and the elevation of IL-1β, IL-18, and IL-33 was observed in the serum or bronchoalveolar lavage fluid (BAL) [95,96,97].